I've written the review to `review.md`. Summary of what it says:

**Recommended status: `critical-gaps`** — 7 findings survived (7 raised, solo so no counterpart to reconcile against). Three are independently critical:

- **F1** — GI-001 self-contradicts: the risk surface calls a client-list leak "GDPR-reportable," but the module ruling excludes `gdpr` on a mistaken premise (B2B contacts aren't outside GDPR's scope — that conflates a lawful basis with a scope exclusion).
- **F2** — the synthesis's "no formal code review" team-reality fact is contradicted by `CLAUDE.md` itself, which already mandates PR review before merge. This also undercuts GI-013's rationale.
- **F3** — GI-006 (FLOOR-ERR) has a blank ruling cell despite a Confident mark — an unrecorded ruling.

Four more are `needs-revision`: thin/unquoted rationale on GI-011 and GI-013, an inconsistent "until paying customers" caveat applied to GI-017 but not GI-016, and a depth-level ledger trail (GI-003) that doesn't show the expected recommend-then-arbitrate sequence (noted as a process point, not a challenge to `high` itself).

I explicitly declined to grade `CLAUDE.md`'s wording/formulation — that's out of this seat's jurisdiction (belongs to `validation-constitution` once the producer authors the surface set) — and flagged that I couldn't access `INTERROGATION-AGENDA.md` in this sandbox, so full ten-dimension coverage isn't something I could certify. Given the verdict, I told the lead not to clear the producer to author yet, and pointed round-cap questions back to `/mochiko:setup`'s own mechanic rather than inventing a number. I also gave a clearly-labeled personal opinion: split the depth by domain (keep money-path rigor high, keep process ritual like weekly meetings/release-notes light or trigger-based for a 2-person team).